HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ACSH Implicates Industry, Retailers In Phthalates Scaremongering

This article was originally published in The Rose Sheet

Executive Summary

The American Council on Science and Health includes phthalates in its list of 2013’s top “unfounded health scares” and suggests that by bowing to NGO pressure and discontinuing use of the ingredients, manufacturers and retailers are contributing to phthalates “hysteria.”

You may also be interested in...



ACSH’s ‘Top 10 Health Scares’ Include Phthalates Again, Formaldehyde

Nonprofit focused on restoring “science and common sense” to personal and public health decisions unveiled its top-10 list of unfounded health scares in December, citing media reports concerning phthalates for the fifth year in a row, as well as fear mongering around formaldehyde in personal-care products.

Maine Proposes Reporting Priority For Phthalates In Some Children’s Products

The Clean and Healthy Maine group asks the state’s Department of the Environment to add four phthalates to its list of priority chemicals, requiring firms to report their use in certain children’s personal care products and other product categories.

Maine Proposes Reporting Priority For Phthalates In Some Children’s Products

The Clean and Healthy Maine group asks the state’s Department of the Environment to add four phthalates to its list of priority chemicals, requiring firms to report their use in certain children’s personal care products and other product categories.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019319

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel